Full-Chain Localization, United for Hearts: RayThink and Neusoft Medical Announce Strategic Partnership to Advance the 'Domestic Smart Cath Lab Project'

Recently, the strategic cooperation signing ceremony between RaysightMed and Neusoft on domestically produced smart catheterization laboratories was successfully held in Shanghai. Professor Pei Zhiqiang, Professor Dong Peng, Mr. Huang Yan, General Manager of Neusoft Medical, and RaysightMedCEO Zheng Lingxiao, Chief Scientist Lan Hongzhi, CTO Ma Jun, and other industry experts and corporate executives gathered on-site to jointly witness the landmark collaboration in domestically produced interventional medical devices, simultaneously completing the project launch ceremony and official signing.

This collaboration closely aligns with the strategic guidance of Academician Ge Junbo: based on the ever-changing global supply chain environment, accelerateBuilding a Domesticated Ecosystem for Cardiac Catheterization Laboratories with Independent and Controllable Full Industry Chain. From the perspective of technical endowment, Neusoft Medical, as a domesticAs a leading DSA enterprise, it establishes the hardware foundation of the catheterization laboratory with its self-developed high-end imaging equipment. RaysightMed, as the leader in integrated solutions for intelligent and precise cardiac diagnosis and treatment, leverages its portfolio of proprietary core products to address the software intelligence gaps in the catheterization laboratory, achieving deep integration of hardware and software.

Professor Pei Zhiqiang stated: Traditional catheterization laboratories are cobbled together with fragmented, multi-brand equipment, resulting in disconnected software and hardware and incompatible data, whereas this strategic partnership achievesDSA Imaging Equipment + AI Diagnostic and Therapeutic Algorithms + Intelligent Interventional Devices Deep Integration, Building Preoperative Planning- Intraoperative Assistance - A closed-loop solution for the entire postoperative follow-up process, truly implementing clinical applications in all-scenario domestic catheterization laboratories nationwide.

Professor Dong Peng mentioned on-site that, with the domestic chips,The acceleration of full domestication across the entire high-end medical device industry chain has propelled Chinese-made medical equipment into a new phase of integrated, mutually beneficial development. It is gratifying to witness the close collaboration between these two companies,Promoting the advancement of domestic innovation.

This signing marks a landmark implementation of collaborative industry-academia-research efforts among domestic medical engineering stakeholders. The two parties will achieve complementary resource integration and technological interoperability, continuously refine localized diagnostic and treatment protocols, and iterate products based on clinical needs in China. This initiative will not only reduce the procurement costs for catheterization laboratory construction in domestic hospitals and alleviate the financial burden on patients, but also consistently promote the enhancement of independent capabilities in domestically produced cardiovascular diagnostic and therapeutic equipment.